Exploring Moroccan Medicinal Plants for Anticancer Therapy Development Through In Silico Studies
Pharmaceuticals · 13.11.2024 · 17 (11) · 1528
DOI: 10.3390/ph17111528 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 13.11.2024. Verfasst von Amal Bouribab und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Casablanca 20600, Morocco. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abdelouahid Samadi, Yasir S. Raouf.
Abstract (Originalsprache)
Background
Angiogenesis is a crucial process in the growth and proliferation of cancer, enabling tumor growth through the formation of new vasculature and the supply of nutrients and oxygen to growing malignant cells. This disease-promoting process can be targeted through the inhibition of tyrosine kinase enzymes.
Objectives
The objective of this study is to evaluate the anticancer potential of various Moroccan plants from different regions. While these plants have a rich history of traditional medicinal use, they have not been extensively investigated as anticancer therapies.
Methods
This study employed a multifaceted approach to evaluate the anticancer potential of various Moroccan plants. Receptor–ligand docking and virtual screening were used to assess the binding affinity of phytocompounds to the EGFR and VEGFR2 receptors. Additionally, predictive pharmacokinetic analyses were conducted to evaluate the ADMET properties of the selected compounds, followed by molecular dynamics simulations to analyze the stability of the receptor–ligand complexes.
Results
In our research, we identified three notable active compounds—catechin, 4-O-glucoside ferulic acid, and 3-glucoside resveratrol—in the Moroccan plant Ajuga iva L. These findings suggest that Ajuga iva L. may possess significant potential for cancer inhibition.
Conclusions
This research highlights the potential of the Moroccan plant Ajuga iva L. as a source of active compounds with significant anticancer properties. Further investigation is essential to validate these findings and explore new therapeutic avenues based on these traditional resources.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Casablanca 20600, Morocco.
- Department of Chemistry, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
ORCID-Profile: El Mehdi Karim, Oussama Abchir, Abdelkbir Errougui, Yasir S Raouf, Abdelouahid Samadi, Samir Chtita
Förderung
- Abdelouahid Samadi
- Yasir S. Raouf
Zitieren
APA
Bouribab, A., Karim, E. M., Khedraoui, M., Abchir, O., Errougui, A., Raouf, Y. S., Samadi, A., & Chtita, S. (2024). Exploring Moroccan Medicinal Plants for Anticancer Therapy Development Through In Silico Studies. Pharmaceuticals, 17(11), 1528. https://doi.org/10.3390/ph17111528
Vancouver
Bouribab A, Karim EM, Khedraoui M, Abchir O, Errougui A, Raouf YS, et al. Exploring Moroccan Medicinal Plants for Anticancer Therapy Development Through In Silico Studies. Pharmaceuticals. 2024;17(11):1528. doi:10.3390/ph17111528
BibTeX
@article{Bouribab2024,
author = {Bouribab, Amal and Karim, El Mehdi and Khedraoui, Meriem and Abchir, Oussama and Errougui, Abdelkbir and Raouf, Yasir S and Samadi, Abdelouahid and Chtita, Samir},
title = {Exploring Moroccan Medicinal Plants for Anticancer Therapy Development Through In Silico Studies},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {11},
pages = {1528},
doi = {10.3390/ph17111528}
}
EUVIMED